3,5-DI-tert-BUTYL-1,2-BENZOQUINONE IN THE SYNTHESIS
445
1353, 1326, 1233. 1H NMR spectrum (CDCl3), δ, ppm:
1.28 s (9H, 9-t-Bu), 1.50 s (9H, 11-t-Bu), 2.66 s (3H,
4-CH3), 2.71 s (3H, 2-CH3), 5.78 br.s (1H, NH), 6.74 d
(1H, 5-H, J = 7.6 Hz), 6.84 d (1H, 10-H, J = 2.38 Hz),
7.04 d (1H, 8-H, J = 2.38 Hz), 7.13 br.s (1H, 1-H),
7.33 d (1H, 6-H, J = 7.69 Hz). Mass spectrum, m/z
(Irel, %): 374 (100) [M]+, 359 (9), 303 (9), 259 (16),
187 (14), 128 (10), 115 (18), 91 (12), 77 (21), 63 (12),
57 (90), 41 (87). Found, %: C 80.15; H 7.99; N 7.42.
C25H30N2O. Calculated, %: C 80.17; H 8.07; N 7.48.
the residue was recrystallized from propan-2-ol. Yield
0.16 g (7%), colorless crystals, mp 139–141°C. IR
spectrum, ν, cm–1: 3353 (NH), 1593, 1567, 1460, 1433,
1
1393, 1367, 1313, 1233. H NMR spectrum (CDCl3),
δ, ppm: 1.29 s (9H, 9-t-Bu), 1.50 s (9H, 11-t-Bu), 2.63 s
(3H, 4-CH3), 2.68 s (3H, 2-CH3), 6.62 s (1H, NH),
6.91 d (1H, 10-H, J = 2.08 Hz), 7.07 d (1H, 8-H, J =
2.08 Hz), 7.16 s (1H, 1-H), 7.59 s (1H, 5-H). Found,
%: C 66.21; H 6.38; Br 17.59; N 6.12. C25H29BrN2O.
Calculated, %: C 66.22; H 6.45; Br 17.62; N 6.18.
4,6-Di-tert-butyl-2-(2-nitrophenylamino)phenol
(VIIIa) and 6,8-di-tert-butyl-1-nitrophenoxazine
(IXa). A mixture of 1.1 g (5 mmol) of 3,5-di-tert-
butyl-1,2-benzoquinone (III) and 0.69 g (5 mmol) of
2-nitroaniline (VIa) was heated for 1 h at 135–140°C.
The melt was cooled and dissolved in a 2:1 mixture of
petroleum ether with chloroform, and the solution was
passed through a column charged with Al2O3 (15×
750 mm) using the same solvent mixture as eluent.
Two fractions were collected. The first orange fraction
contained compound VIIIa, and the second violet
fraction, compound IXa. The solvent was distilled off
from each fraction, and the residue was recrystallized
from propan-2-ol.
9,11-Di-tert-butyl-2,4,5-trimethyl-7H-quinolino-
[4,5-bc][1,5]benzoxazepine (Vb) was synthesized in
a similar way from 1.102 g of compound IVb. Yield
0.98 g (51%), light yellow crystals, mp 166–168°C. IR
spectrum, ν, cm–1: 3350 (NH), 1633, 1606, 1667, 1473,
1
1447, 1380, 1353, 1313, 1233. H NMR spectrum
(CDCl3), δ, ppm: 1.28 s (9H, 9-t-Bu), 1.50 s (9H,
11-t-Bu), 2.40 s (3H, 5-CH3), 2.63 s (3H, 4-CH3),
2.70 s (3H, 2-CH3), 5.73 br.s (1H, NH), 6.70 s (1H,
6-H), 6.83 d (1H, 10-H, J = 2.2 Hz), 7.02 d (1H, 8-H,
J = 2.2 Hz), 7.07 s (1H, 1-H). Found, %: C 80.35;
H 8.27; N 7.18. C26H32N2O. Calculated, %: C 80.37;
H 8.30; N 7.21.
9,11-Di-tert-butyl-2,4,6-trimethyl-7H-quinolino-
[4,5-bc][1,5]benzoxazepine (Vc) was synthesized in
a similar way from 1.102 g of compound IVc. Yield
1.15 g (59%), light yellow crystals, mp 206–208°C. IR
spectrum, ν, cm–1: 3406 (NH), 1593, 1567, 1460, 1393,
Compound VIIIa. Yield 0.58 g (34%), yellow–
1
orange crystals, mp 105–107°C. H NMR spectrum
(CDCl3), δ, ppm: 1.26 s (9H, 4-t-Bu), 1.42 s (9H,
6-t-Bu), 5.77 s (1H, OH), 6.65 d (1H, 6′-H, J =
7.69 Hz), 6.80 t (1H, 5′-H, J = 7.24 Hz), 7.00 d (1H,
5-H, J = 2.38 Hz), 7.33 d (1H, 3-H, J = 2.38 Hz),
7.36 t (1H, 4′-H, J = 7.04 Hz), 8.22 d (1H, 3′-H, J =
7.14 Hz), 8.88 s (1H, NH). Found, %: C 70.12; H 7.58;
N 8.15. C20H26N2O3. Calculated, %: C 70.15; H 7.65;
N 8.18.
1
1433, 1367, 1313, 1233. H NMR spectrum, δ, ppm:
1.29 s (9H, 9-t-Bu), 1.50 s (9H, 11-t-Bu), 2.49 s (3H,
4-CH3), 2.64 s (3H, 6-CH3), 2.69 s (3H, 2-CH3), 5.81 s
(1H, NH), 6.83 d (1H, 10-H, J 2.28 Hz), 7.04 d (1H,
8-H, J = 2.28 Hz), 7.12 s (1H, 5-H), 7.29 s (1H, 1-H).
Mass spectrum, m/z (Irel, %): 398 (95) [M]+, 373 (5),
315 (6), 301 (6), 287 (5), 273 (14), 194 (13), 128 (11),
115 (19), 91 (16), 77 (20), 57 (98), 41 (100). Found,
%: C 80.36; H 8.25; N 7.18. C26H32N2O. Calculated,
%: C 80.37; H 8.30; N 7.21.
Compound IXa. Yield 0.07 g (4%), bright violet
1
crystals, mp 101–103°C. H NMR spectrum (CDCl3),
δ, ppm: 1.24 s (9H, 8-t-Bu), 1.36 s (9H, 6-t-Bu), 6.48 d
(1H, 7-H, J = 2.2 Hz), 6.56 t (1H, 3-H, J = 8.78 Hz),
6.80 d (1H, 4-H, J = 2.2 Hz), 6.82 d (1H, 2-H, J =
6.66 Hz), 7.58 d (1H, 4-H, J = 7.62 Hz), 8.91 br.s (1H,
NH). Found, %: C 70.55; H 7.04; N 8.20. C20H24N2O3.
Calculated, %: C 70.57; H 7.11; N 8.23.
6-Bromo-9,11-di-tert-butyl-2,4-dimethyl-7H-
quinolino[4,5-bc][1,5]benzoxazepine (Vd). A mixture
of 1.1 g (5 mmol) of 3,5-di-tert-butyl-1,2-benzoqui-
none (III), 1.43 g (5 mmol) of 5-amino-6-bromo-4-
chloro-2,8-dimethylquinoline (IVd), and 200 mg of
p-toluenesulfonic acid was heated for 30 min at 160–
170°C. The melt was cooled and dissolved in a 1:1
mixture of petroleum ether with chloroform, and the
solution was passed through a column charged with
Al2O3 (15×750 mm) using the same solvent mixture as
eluent. The first colorless fraction was evaporated, and
4,6-Di-tert-butyl-2-(4-methyl-2-nitrophenyl-
amino)phenol (VIIIb). A mixture of 1.1 g (5 mmol) of
3,5-di-tert-butyl)-1,2-benzoquinone (III), 0.69 g
(5 mmol) of 2-nitroaniline (VIa), and 0.56 g of 3,5-di-
tert-butylbenzene-1,2-diol was heated for 1 h at 135–
140°C. The melt was cooled and dissolved in a 2:1
mixture of petroleum ether with chloroform, and the
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 45 No. 3 2009